Popular Articles

Obama Pledges $73M To Zimbabwe
Following talks with Zimbabwean Prime Minister Morgan Tsvangirai at the White House Friday, President Obama pledged $73 million in aid to the country, AFP/Google.com reports (Carmichael, AFP/Google.com, 6/13). The U.S. aid, however "will not be going to the government directly because we continue to be concerned about consolidating democracy, human rights and rule of law," Obama said (Stolberg, New York Times, 6/13), but channeled through appropriate aid agencies (ZimOnline, 6/15).
generic viagra online
African Scientists Ask Developed Countries For Greater Investment In African Research
The Network of African Science Academies (NASAC) issued a statement (pdf) asking developed countries to establish training programs that would allow African students to stay in Africa or other developing countries in effort to curb the "tide of African talent leaving the continent"s universities," CNN reports (Wong, CNN, 6/22).
News of the day
Louisiana Department Of Health And Hospitals Offers Grant To Improve Primary Health Care Services
The Department of Health and Hospitals" Bureau of Primary Care and Rural Health is offering grants to medically underserved, rural and urban areas to expand access to primary care services.
Sexual Health

Prescribing Sunshine For Multiple Sclerosis?

Could a holiday in the sun reduce the risk of developing multiple sclerosis? In a recent review for F1000 Medicine Reports, Bridget Bagert and Dennis Bourdette highlight recent advances in potential treatments. Multiple sclerosis (MS) results from a failure of the body to recognize itself. The immune system attacks and destroys the sheath that protects nerve fibres, as if it were a foreign body or infection. Vitamin D, which is produced in the skin in response to natural sunlight, is an immune system regulator. This might explain why MS is less common in sunnier countries. Giving MS sufferers vitamin D pills - or encouraging them to spend more time in the sun - might be a cheap and easy treatment. Bagert and Bourdette point out that oral vitamin D therapy is now in phase II clinical trials, to see how well it works and how much would be needed. They say "The arrival of effective oral agents will give MS patients more therapeutic options and will be a major advance in the global effort to alter the natural history of this chronic disease". Faculty of 1000: Biology and Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):